Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder

Background: Effective screening for alcohol-associated liver disease is relevant in the context of chronic, excessive alcohol consumption. Patients with alcohol-associated liver disease are often not diagnosed until their liver disease is decompensated. We analyzed the prevalence and associations of...

Descripción completa

Detalles Bibliográficos
Autores: Zuluaga Blanco, Yenny Paola|||0000-0002-0247-0351, Fuster, Daniel|||0000-0003-1262-5860, Blanes, Rafael, Hernandez Rubio, Anna|||0000-0001-8612-7827, Miquel, Laia, Torrens, Marta, Rubio, Gabriel, Bolao, Ferran|||0000-0002-9104-6615, Liangpunsakul, Suthat|||0000-0002-6504-8123, Abellí-Deulofeu, Enric, Rodríguez de Fonseca, Fernando|||0000-0002-4516-5795, Muga, Roberto|||0000-0001-6301-431X
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:292221
Acceso en línea:https://ddd.uab.cat/record/292221
https://dx.doi.org/urn:doi:10.1111/acer.15345
Access Level:acceso abierto
Palabra clave:Advanced liver fibrosis
Alcohol-associated liver disease
Binge drinking
FIB-4 index
Leukopenia
Descripción
Sumario:Background: Effective screening for alcohol-associated liver disease is relevant in the context of chronic, excessive alcohol consumption. Patients with alcohol-associated liver disease are often not diagnosed until their liver disease is decompensated. We analyzed the prevalence and associations of Fibrosis-4 index (FIB-4) values suggestive of advanced liver fibrosis in patients referred for their first treatment of alcohol use disorder (AUD). Methods: We conducted a cross-sectional, multicenter study of noncirrhotic individu-als referred for their first AUD treatment between March 2013 and April 2021. We obtained sociodemographic data, substance use characteristics, and blood samples at admission. We considered a FIB-4 value ≥2.67 suggestive of advanced liver fibrosis and used logistic regression analyses to identify features associated with this value. Results: We included 604 patients (67% male), with a median age at admission of 48 years [IQR: 41-56 years]. The median duration of regular alcohol consumption was 21 years [IQR: 18-30 years] and the median alcohol consumption was 105 standard drink units (SDU)/week [IQR: 63-160 SDU/week]. A FIB-4 value ≥ 2.67 was present in 19.3% of cases. These patients reported more frequent binge drinking (75.4% vs. 66%, p= 0.05) than those with FIB-4 values below 2.67. In multivariate analysis, a history of binge drinking (OR 1.9, 95% CI, 1.05-3.47), anemia (OR 2.95, 95% CI, 1.42-6.11), leukopenia (OR 7.46, 95% CI, 2.07-26.8), and total serum bilirubin.